Savara, Inc. (SVRA)
5.565
-0.02
(-0.45%)
USD |
NASDAQ |
Aug 24, 16:00
5.565
0.00 (0.00%)
After-Hours: 19:20
Savara Price to Book Value : 7.957 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 7.992 |
| August 20, 2026 | 7.849 |
| August 19, 2026 | 7.978 |
| August 18, 2026 | 7.678 |
| August 17, 2026 | 7.678 |
| August 14, 2026 | 7.692 |
| August 13, 2026 | 7.535 |
| August 12, 2026 | 8.150 |
| August 11, 2026 | 7.964 |
| August 10, 2026 | 8.192 |
| August 07, 2026 | 8.336 |
| August 06, 2026 | 8.278 |
| August 05, 2026 | 7.878 |
| August 04, 2026 | 7.735 |
| August 03, 2026 | 7.621 |
| July 31, 2026 | 7.806 |
| July 30, 2026 | 7.921 |
| July 29, 2026 | 7.549 |
| July 28, 2026 | 7.621 |
| July 27, 2026 | 7.764 |
| July 24, 2026 | 7.878 |
| July 23, 2026 | 8.221 |
| July 22, 2026 | 8.078 |
| July 21, 2026 | 8.350 |
| July 20, 2026 | 7.849 |
| Date | Value |
|---|---|
| July 17, 2026 | 7.892 |
| July 16, 2026 | 7.892 |
| July 15, 2026 | 8.307 |
| July 14, 2026 | 8.135 |
| July 13, 2026 | 8.207 |
| July 10, 2026 | 8.621 |
| July 09, 2026 | 8.993 |
| July 08, 2026 | 9.122 |
| July 07, 2026 | 8.879 |
| July 06, 2026 | 8.864 |
| July 02, 2026 | 8.893 |
| July 01, 2026 | 8.664 |
| June 30, 2026 | 8.807 |
| June 29, 2026 | 7.019 |
| June 26, 2026 | 6.868 |
| June 25, 2026 | 7.019 |
| June 24, 2026 | 6.787 |
| June 23, 2026 | 6.728 |
| June 22, 2026 | 6.624 |
| June 18, 2026 | 6.402 |
| June 17, 2026 | 6.263 |
| June 16, 2026 | 6.170 |
| June 15, 2026 | 6.204 |
| June 12, 2026 | 6.123 |
| June 11, 2026 | 6.135 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gilead Sciences, Inc. | 15.40 |
| Insmed, Inc. | 35.74 |
| United Therapeutics Corp. | 3.421 |
| Vertex Pharmaceuticals, Inc. | 6.854 |
| SELLAS Life Sciences Group, Inc. | 21.01 |
Price to Book Value Related Metrics
| PEG Ratio | -0.7785 |
| Price | 5.565 |
| Earnings Yield | -10.36% |
| Market Cap | 1.143B |
| PEGY Ratio | -0.7785 |